|
Characteristics a
| |
Alive
|
Died
|
P
b
|
|
No. of subjects
|
3090
|
2031
|
1059
| |
|
Age (years), mean (SD)
|
73.3 (10.4)
|
69.0 (8.5)
|
81.5 (8.5)
|
<0.001
|
|
Female, n (%)
|
1969 (63.7)
|
1298 (63.9)
|
671 (63.4)
|
0.764
|
|
Education, n (%)
|
|
Elementary or middle school
|
505 (16.4)
|
223 (11.0)
|
282 (26.7)
|
–
|
|
High school
|
1536 (49.8)
|
978 (48.2)
|
558 (52.8)
|
0.003
|
|
University or above
|
1046 (33.9)
|
830 (40.9)
|
216 (20.5)
|
0.020
|
|
Smoking, n (%)
|
|
Never
|
1442 (47.0)
|
908 (45.0)
|
534 (50.9)
|
–
|
|
Former smoking
|
1178 (38.4)
|
812 (40.2)
|
366 (34.9)
|
0.022
|
|
Current smoking
|
447 (14.6)
|
298 (14.8)
|
149 (14.2)
|
<0.001
|
|
Heavy alcohol drinking, n (%)
|
495 (16.1)
|
376 (18.6)
|
119 (11.4)
|
0.406
|
|
Physical inactivity, n (%)
|
955 (30.9)
|
409 (20.1)
|
546 (51.6)
|
<0.001
|
|
Obesity, n (%)
|
374 (12.1)
|
278 (13.7)
|
96 (9.1)
|
0.539
|
|
Hypertension, n (%)
|
2318 (75.3)
|
1448 (71.4)
|
870 (82.8)
|
0.887
|
|
Diabetes, n (%)
|
293 (9.5)
|
146 (7.2)
|
147 (14.0)
|
<0.001
|
|
Total cholesterol (mmol/l), mean (SD)
|
6.0 (1.1)
|
6.1 (1.1)
|
5.8 (1.2)
|
<0.001
|
|
Use of cholesterol-lowering drugs, n (%)
|
381 (12.4)
|
270 (13.3)
|
111 (10.6)
|
0.784
|
|
Cognitive impairment, n (%)
|
432 (14.0)
|
95 (4.7)
|
337 (31.9)
|
<0.001
|
|
Mobility limitation, n (%)
|
826 (26.9)
|
231 (11.4)
|
595 (57.2)
|
<0.001
|
|
APOE ε4, n (%)
|
835 (29.1)
|
569 (29.2)
|
266 (28.7)
|
0.046
|
